New lease could save Calidi Biotherapeutics (NYSE American: CLDI) $1.1M yearly
Rhea-AI Filing Summary
Calidi Biotherapeutics, Inc. entered into a new lease for approximately 9,038 rentable square feet of office and laboratory space at 5580 Morehouse Drive in San Diego. The initial 44‑month term is scheduled to run from October 1, 2026 through May 31, 2030, with one three‑year renewal option at fair market rent.
By terminating its existing lease at 4475 Executive Drive effective September 30, 2026 and relocating to the new premises, the company estimates annual savings of about $1.1 million in rent and facility expenses. Calidi must post an irrevocable $113,574.78 letter of credit within 10 days, generally kept in place until at least 120 days after lease expiration.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
4 items: 1.01, 1.02, 2.03, 9.01
4 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 1.02
Termination of a Material Definitive Agreement
Business
A significant contract was terminated, which may affect business operations or revenue.
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Estimated annual rent and facility savings: approximately $1.1 million per year
New premises size: 9,038 rentable square feet
Letter of credit amount: $113,574.78
+5 more
8 metrics
Estimated annual rent and facility savings
approximately $1.1 million per year
Estimated savings from terminating the existing lease and entering the new lease
New premises size
9,038 rentable square feet
Office and laboratory space at 5580 Morehouse Drive, Suite 120, San Diego
Letter of credit amount
$113,574.78
Irrevocable letter of credit required within 10 calendar days of executing the new lease
Initial lease term
44 months
Scheduled from October 1, 2026 through May 31, 2030
Lease termination date for prior premises
September 30, 2026
Effective termination date of the prior lease at 4475 Executive Drive
Renewal option length
3 years
Single option to extend the new lease at then-prevailing fair market rental rate
Post-expiration LOC duration
120 days
Letter of credit generally must remain in effect at least this long after lease expiration
Grace period in existing premises
up to 14 days
Maximum stay after substantial completion of the new premises if not ready by September 30, 2026
Key Terms
material definitive agreement, letter of credit, holdover provisions, Emerging growth company
4 terms
material definitive agreement regulatory
"Item 1.01. Entry into a Material Definitive Agreement."
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
letter of credit financial
"deliver an irrevocable letter of credit in the amount of $113,574.78."
A letter of credit is a bank’s written promise to pay a seller on behalf of a buyer once specified shipping or delivery documents are presented, acting like a guaranteed cashier’s check that only pays when the agreed conditions are met. Investors care because letters of credit reduce payment and counterparty risk, affect a company’s working capital and credit exposure, and can influence deal certainty in contracts, trade financing, and acquisitions.
holdover provisions regulatory
"If the Company fails to timely vacate... the holdover provisions of the Prior Lease will apply."
Emerging growth company regulatory
"Emerging growth company Item 1.01."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What new lease did Calidi Biotherapeutics (CLDI) sign in July 2026?
Calidi Biotherapeutics entered a new lease for 9,038 rentable square feet of office and lab space at 5580 Morehouse Drive, San Diego. The initial term is 44 months, from October 1, 2026 through May 31, 2030, with one three‑year renewal option.
How much does Calidi Biotherapeutics (CLDI) expect to save from the new lease?
The company estimates the lease change will save about $1.1 million per year in rent and facility-related expenses. These savings result from terminating the prior lease at 4475 Executive Drive and relocating operations to the smaller, newly leased premises at 5580 Morehouse Drive.
What security is Calidi Biotherapeutics (CLDI) providing under the new lease?
Within 10 calendar days of signing, Calidi must deliver an irrevocable letter of credit for $113,574.78. This letter of credit generally remains in effect until at least 120 days after the lease expires and may be drawn after specified default events.
When does Calidi Biotherapeutics’ (CLDI) prior lease now end?
Under a Lease Termination Agreement, the prior lease at 4475 Executive Drive will terminate effective September 30, 2026. If the new premises are not substantially complete by then, Calidi may remain up to 14 days after completion before surrendering the existing space.
Does Calidi Biotherapeutics (CLDI) owe any early termination fee on the old lease?
The Lease Termination Agreement explicitly states that it does not provide for an early termination fee to the prior landlord. However, provisions of the prior lease that expressly survive expiration or earlier termination will continue to remain in effect after the termination date.